Levosimendan Carinopharm

Levosimendan, the active ingredient in Levosimendan Carinopharm, is a calcium sensitizer / inodilator presented as an intravenous solution for intravenous use. It is employed to improve cardiac contractility in adults with acute decompensated heart failure or severe heart failure requiring inotropic support.

GNH USA supplies Levosimendan Carinopharm as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Levosimendan acts on the cardiovascular system to enhance cardiac performance in acute heart failure settings.

- Acute decompensated heart failure: improves cardiac output and relieves symptoms of congestion. - Severe heart failure requiring inotropic support: provides inotropic assistance without increasing intracellular calcium. - Low‑output syndrome after cardiac surgery: helps restore adequate circulation in postoperative patients.

Levosimendan may be associated with a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects: - Hypotension: reduction in blood pressure, especially after rapid infusion. - Headache: mild to moderate intensity. - Nausea: occasional gastrointestinal discomfort. - Tachycardia: increased heart rate. - Dizziness: sensation of light‑headedness.

Serious or Rare Side Effects: - Severe hypotension: may require vasopressor support. - Arrhythmias: ventricular or atrial rhythm disturbances. - Myocardial ischemia: chest pain due to reduced coronary perfusion. - Allergic reactions: rash, pruritus, or anaphylaxis. - Pulmonary edema: fluid accumulation in lungs.

When using Levosimendan, clinicians should observe several precautionary measures to ensure patient safety. - Hypotension: monitor blood pressure continuously during and after infusion. - Cardiac arrhythmias: observe ECG for new or worsening rhythm disturbances. - Renal impairment: assess renal function and adjust monitoring as needed. - Hepatic impairment: use with caution in patients with liver dysfunction. - Concomitant vasodilators: avoid additive blood pressure lowering effects. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Levosimendan can interact with other medicines, influencing its efficacy or safety profile.

Major Interactions (Avoid): - Sodium nitroprusside: combined use may cause profound hypotension. - Other inotropes (e.g., dobutamine): additive inotropic effect can increase cardiac stress. - Phosphodiesterase‑5 inhibitors: risk of severe vasodilation and hypotension.

Moderate Interactions (Monitor Closely): - Beta‑blockers: may blunt desired increase in heart rate. - ACE inhibitors or ARBs: monitor for excessive blood pressure drop. - Diuretics: watch for volume depletion and electrolyte imbalance.